Terms: = Endocrine gland cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2
28 results:
1. Evaluation of the performance of and interobserver agreement on postoperative baseline CT findings in the identification of locoregional recurrence in patients with pancreatic ductal adenocarcinoma.
Akkaya H; Özdemir S; Dilek O; Topaloglu AC; Bayhan AZ; Taş ZA; Gökler C; Gülek B
Abdom Radiol (NY); 2023 Oct; 48(10):3135-3146. PubMed ID: 37517056
[TBL] [Abstract] [Full Text] [Related]
2. Consumption of health resources in older people with differentiated thyroid carcinoma: a multicenter analysis.
Díez JJ; Anda E; Alcazar V; Isidro ML; Familiar C; Paja M; Martín Rojas-Marcos P; Pérez-Corral B; Navarro E; Romero-Lluch AR; Oleaga A; Pamplona MJ; Fernández-García JC; Megía A; Manjón-Miguélez L; Sánchez-Ragnarsson C; Iglesias P; Sastre J
Endocrine; 2023 Sep; 81(3):521-531. PubMed ID: 37103683
[TBL] [Abstract] [Full Text] [Related]
3. Perineural Invasion in Papillary Thyroid cancer: A Rare Indicator of Aggressive Disease.
Limberg J; Lee-Saxton YJ; Egan CE; AlAnazi A; Easthausen I; Stefanova D; Stamatiou A; Beninato T; Zarnegar R; Scognamiglio T; Fahey TJ; Finnerty BM
Ann Surg Oncol; 2023 Jun; 30(6):3570-3577. PubMed ID: 36897419
[TBL] [Abstract] [Full Text] [Related]
4. Expanding the Spectrum of
De Leo A; Serban D; Maloberti T; Sanza V; Coluccelli S; Altimari A; Gruppioni E; Chiarucci F; Corradini AG; Repaci A; Colapinto A; Nannini M; Pantaleo MA; de Biase D; Tallini G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835466
[TBL] [Abstract] [Full Text] [Related]
5. Patient and Parent Perspectives on Testicular Adrenal Rest Tumors in Congenital Adrenal Hyperplasia.
Nebesio TD; Kim MS; Szymanski KM; Kokorowski PJ; Geffner ME; Eugster EA;
Horm Res Paediatr; 2023; 96(5):518-522. PubMed ID: 36652933
[TBL] [Abstract] [Full Text] [Related]
6. Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling.
Liu S; Chen X; Huang K; Xiong X; Shi Y; Wang X; Pan X; Cong Y; Sun Y; Ge L; Xu J; Jia X
Exp Cell Res; 2023 Jan; 422(2):113438. PubMed ID: 36435219
[TBL] [Abstract] [Full Text] [Related]
7. cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic cancer.
Tasaki Y; Suzuki M; Katsushima K; Shinjo K; Iijima K; Murofushi Y; Naiki-Ito A; Hayashi K; Qiu C; Takahashi A; Tanaka Y; Kawaguchi T; Sugawara M; Kataoka T; Naito M; Miyata K; Kataoka K; Noda T; Gao W; Kataoka H; Takahashi S; Kimura K; Kondo Y
Cancer Res; 2021 Apr; 81(7):1654-1666. PubMed ID: 33648930
[TBL] [Abstract] [Full Text] [Related]
8. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and ddx3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting ddx3 and regulating the PTEN/PI3K/AKT signaling pathway.
Ni J; Chen L; Ling L; Wu M; Ren Q; Zhu W
Mol Med Rep; 2020 Aug; 22(2):1277-1284. PubMed ID: 32626994
[TBL] [Abstract] [Full Text] [Related]
10. Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis.
Tan E; Song J; Lam S; D'Souza M; Crawford M; Sandroussi C
Int J Surg; 2019 Dec; 72():59-68. PubMed ID: 31580919
[TBL] [Abstract] [Full Text] [Related]
11. Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.
Winham SJ; Larson NB; Armasu SM; Fogarty ZC; Larson MC; McCauley BM; Wang C; Lawrenson K; Gayther S; Cunningham JM; Fridley BL; Goode EL
Hum Mol Genet; 2019 Apr; 28(8):1331-1342. PubMed ID: 30576442
[TBL] [Abstract] [Full Text] [Related]
12. Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary.
Xu Y; Bi R; Xiao Y; Tu X; Li M; Li A; Shan L; Zhou S; Yang W
Diagn Pathol; 2017 Dec; 12(1):87. PubMed ID: 29273082
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.
Goschzik T; Gessi M; Dreschmann V; Gebhardt U; Wang L; Yamaguchi S; Wheeler DA; Lauriola L; Lau CC; Müller HL; Pietsch T
J Neuropathol Exp Neurol; 2017 Feb; 76(2):126-134. PubMed ID: 28069929
[TBL] [Abstract] [Full Text] [Related]
14. CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells.
Davidson B
Hum Pathol; 2016 Dec; 58():123-127. PubMed ID: 27589896
[TBL] [Abstract] [Full Text] [Related]
15. [Ovarian clear cell carcinoma derived from endometriotic cyst: a clinicopathological analysis of 54 cases].
Zhu Q; Lu Y; Rao Y; Ning Y; Qu Y; Wang L; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):838-42. PubMed ID: 26887772
[TBL] [Abstract] [Full Text] [Related]
16. Racial disparities in survival in malignant germ cell tumors of the ovary.
Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J
Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470
[TBL] [Abstract] [Full Text] [Related]
17. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review.
Clement SC; Peeters RP; Ronckers CM; Links TP; van den Heuvel-Eibrink MM; Nieveen van Dijkum EJ; van Rijn RR; van der Pal HJ; Neggers SJ; Kremer LC; van Eck-Smit BL; van Santen HM
Cancer Treat Rev; 2015 Dec; 41(10):925-34. PubMed ID: 26421813
[TBL] [Abstract] [Full Text] [Related]
18. The Clinical and Pathological Significance of Nectin-2 and ddx3 Expression in Pancreatic Ductal Adenocarcinomas.
Liang S; Yang Z; Li D; Miao X; Yang L; Zou Q; Yuan Y
Dis Markers; 2015; 2015():379568. PubMed ID: 26294807
[TBL] [Abstract] [Full Text] [Related]
19. Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.
Hagerstrand D; Tong A; Schumacher SE; Ilic N; Shen RR; Cheung HW; Vazquez F; Shrestha Y; Kim SY; Giacomelli AO; Rosenbluh J; Schinzel AC; Spardy NA; Barbie DA; Mermel CH; Weir BA; Garraway LA; Tamayo P; Mesirov JP; Beroukhim R; Hahn WC
Cancer Discov; 2013 Sep; 3(9):1044-57. PubMed ID: 23764425
[TBL] [Abstract] [Full Text] [Related]
20. Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer.
Wang Y; Ji M; Wang W; Miao Z; Hou P; Chen X; Xu F; Zhu G; Sun X; Li Y; Condouris S; Liu D; Yan S; Pan J; Xing M
Endocr Relat Cancer; 2008 Mar; 15(1):183-90. PubMed ID: 18310286
[TBL] [Abstract] [Full Text] [Related]
[Next]
